Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.

Poulard C, Kim HN, Fang M, Kruth K, Gagnieux C, Gerke DS, Bhojwani D, Kim YM, Kampmann M, Stallcup MR, Pufall MA.

Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3052-3061. doi: 10.1073/pnas.1816254116. Epub 2019 Feb 7.

2.

Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death.

Poulard C, Baulu E, Lee BH, Pufall MA, Stallcup MR.

Cell Death Dis. 2018 Oct 10;9(10):1038. doi: 10.1038/s41419-018-1110-z.

3.

Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells.

Jin ML, Kim YW, Jin HL, Kang H, Lee EK, Stallcup MR, Jeong KW.

Int J Cancer. 2018 Dec 1;143(11):2871-2883. doi: 10.1002/ijc.31853. Epub 2018 Oct 4.

4.

Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5.

Lee BH, Stallcup MR.

PLoS One. 2018 May 8;13(5):e0196965. doi: 10.1371/journal.pone.0196965. eCollection 2018.

5.

A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP.

Poulard C, Bittencourt D, Wu DY, Hu Y, Gerke DS, Stallcup MR.

EMBO Rep. 2017 Aug;18(8):1442-1459. doi: 10.15252/embr.201744060. Epub 2017 Jun 14.

6.

Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes.

Lee BH, Stallcup MR.

J Biol Chem. 2017 Jun 2;292(22):9320-9334. doi: 10.1074/jbc.M117.782607. Epub 2017 Apr 5.

7.

Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.

Yu EJ, Kim SH, Kim HJ, Heo K, Ou CY, Stallcup MR, Kim JH.

Oncogene. 2016 Jun 30;35(26):3410-8. doi: 10.1038/onc.2015.401. Epub 2015 Oct 19.

8.

Identifying differential transcription factor binding in ChIP-seq.

Wu DY, Bittencourt D, Stallcup MR, Siegmund KD.

Front Genet. 2015 Apr 29;6:169. doi: 10.3389/fgene.2015.00169. eCollection 2015.

9.

Selective coregulator function and restriction of steroid receptor chromatin occupancy by Hic-5.

Chodankar R, Wu DY, Gerke DS, Stallcup MR.

Mol Endocrinol. 2015 May;29(5):716-29. doi: 10.1210/me.2014-1403. Epub 2015 Mar 12.

10.

Role of distinct surfaces of the G9a ankyrin repeat domain in histone and DNA methylation during embryonic stem cell self-renewal and differentiation.

Bittencourt D, Lee BH, Gao L, Gerke DS, Stallcup MR.

Epigenetics Chromatin. 2014 Oct 22;7:27. doi: 10.1186/1756-8935-7-27. eCollection 2014.

11.

Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators.

Wu DY, Ou CY, Chodankar R, Siegmund KD, Stallcup MR.

Nucl Recept Signal. 2014 Nov 4;12:e002. doi: 10.1621/nrs.12002. eCollection 2014.

12.

Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes.

Schiller BJ, Chodankar R, Watson LC, Stallcup MR, Yamamoto KR.

Genome Biol. 2014 Jul 31;15(7):418. doi: 10.1186/s13059-014-0418-y.

13.

Coregulator cell cycle and apoptosis regulator 1 (CCAR1) positively regulates adipocyte differentiation through the glucocorticoid signaling pathway.

Ou CY, Chen TC, Lee JV, Wang JC, Stallcup MR.

J Biol Chem. 2014 Jun 13;289(24):17078-86. doi: 10.1074/jbc.M114.548081. Epub 2014 May 8.

14.

Hic-5 is a transcription coregulator that acts before and/or after glucocorticoid receptor genome occupancy in a gene-selective manner.

Chodankar R, Wu DY, Schiller BJ, Yamamoto KR, Stallcup MR.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4007-12. doi: 10.1073/pnas.1400522111. Epub 2014 Mar 3.

15.

Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.

Jeong KW, Andreu-Vieyra C, You JS, Jones PA, Stallcup MR.

Nucleic Acids Res. 2014 Feb;42(4):2245-56. doi: 10.1093/nar/gkt1236. Epub 2013 Nov 27.

16.

Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Balasubramaniam S, Comstock CE, Ertel A, Jeong KW, Stallcup MR, Addya S, McCue PA, Ostrander WF Jr, Augello MA, Knudsen KE.

Clin Cancer Res. 2013 May 15;19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14.

17.

cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1.

Hoang T, Fenne IS, Madsen A, Bozickovic O, Johannessen M, Bergsvåg M, Lien EA, Stallcup MR, Sagen JV, Moens U, Mellgren G.

Endocrinology. 2013 Apr;154(4):1513-27. doi: 10.1210/en.2012-2049. Epub 2013 Mar 5.

18.

G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes.

Bittencourt D, Wu DY, Jeong KW, Gerke DS, Herviou L, Ianculescu I, Chodankar R, Siegmund KD, Stallcup MR.

Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19673-8. doi: 10.1073/pnas.1211803109. Epub 2012 Nov 14.

19.

SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis.

Yu EJ, Kim SH, Kim MJ, Seo WY, Song KA, Kang MS, Yang CK, Stallcup MR, Kim JH.

Oncogene. 2013 Aug 29;32(35):4160-8. doi: 10.1038/onc.2012.420. Epub 2012 Sep 17.

20.

Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.

Won Jeong K, Chodankar R, Purcell DJ, Bittencourt D, Stallcup MR.

Mol Endocrinol. 2012 Jun;26(6):955-66. doi: 10.1210/me.2012-1066. Epub 2012 Apr 27.

21.

Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription.

Purcell DJ, Khalid O, Ou CY, Little GH, Frenkel B, Baniwal SK, Stallcup MR.

J Cell Biochem. 2012 Jul;113(7):2406-14. doi: 10.1002/jcb.24114.

22.

Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells.

Sharma S, Gerke DS, Han HF, Jeong S, Stallcup MR, Jones PA, Liang G.

Epigenetics Chromatin. 2012 Jan 27;5(1):3. doi: 10.1186/1756-8935-5-3.

23.

Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription.

Kim K, Jeong KW, Kim H, Choi J, Lu W, Stallcup MR, An W.

Oncogene. 2012 Sep 27;31(39):4290-301. doi: 10.1038/onc.2011.605. Epub 2012 Jan 16.

24.

Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells.

Ianculescu I, Wu DY, Siegmund KD, Stallcup MR.

J Biol Chem. 2012 Feb 3;287(6):4000-13. doi: 10.1074/jbc.M111.300194. Epub 2011 Dec 15. Erratum in: J Biol Chem. 2012 Oct 19;287(43):35985.

25.

Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation.

Jeong KW, Kim K, Situ AJ, Ulmer TS, An W, Stallcup MR.

Nat Struct Mol Biol. 2011 Nov 13;18(12):1358-65. doi: 10.1038/nsmb.2153.

26.

A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation.

Purcell DJ, Jeong KW, Bittencourt D, Gerke DS, Stallcup MR.

J Biol Chem. 2011 Dec 9;286(49):41963-71. doi: 10.1074/jbc.M111.298463. Epub 2011 Oct 8.

27.

Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.

Yu EJ, Kim SH, Heo K, Ou CY, Stallcup MR, Kim JH.

Nucleic Acids Res. 2011 Sep 1;39(16):6932-43. doi: 10.1093/nar/gkr347. Epub 2011 May 19.

28.

A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.

Ou CY, LaBonte MJ, Manegold PC, So AY, Ianculescu I, Gerke DS, Yamamoto KR, Ladner RD, Kahn M, Kim JH, Stallcup MR.

Mol Cancer Res. 2011 May;9(5):660-70. doi: 10.1158/1541-7786.MCR-10-0223. Epub 2011 Apr 8.

29.

Roles of protein arginine methylation in DNA damage signaling pathways is CARM1 a life-or-death decision point?

Lee YH, Stallcup MR.

Cell Cycle. 2011 May 1;10(9):1343-4. Epub 2011 May 1. No abstract available.

30.

Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation.

Lee YH, Bedford MT, Stallcup MR.

Genes Dev. 2011 Jan 15;25(2):176-88. doi: 10.1101/gad.1975811.

31.

A chloroacetamidine-based inactivator of protein arginine methyltransferase 1: design, synthesis, and in vitro and in vivo evaluation.

Obianyo O, Causey CP, Osborne TC, Jones JE, Lee YH, Stallcup MR, Thompson PR.

Chembiochem. 2010 Jun 14;11(9):1219-23. doi: 10.1002/cbic.201000209. No abstract available.

32.

Recruitment of the SWI/SNF chromatin remodeling complex to steroid hormone-regulated promoters by nuclear receptor coactivator flightless-I.

Jeong KW, Lee YH, Stallcup MR.

J Biol Chem. 2009 Oct 23;284(43):29298-309. doi: 10.1074/jbc.M109.037010. Epub 2009 Aug 31.

33.

Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.

Ou CY, Kim JH, Yang CK, Stallcup MR.

J Biol Chem. 2009 Jul 31;284(31):20629-37. doi: 10.1074/jbc.M109.014332. Epub 2009 Jun 11.

34.

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.

Haiman CA, Garcia RR, Hsu C, Xia L, Ha H, Sheng X, Le Marchand L, Kolonel LN, Henderson BE, Stallcup MR, Greene GL, Press MF.

BMC Cancer. 2009 Jan 30;9:43. doi: 10.1186/1471-2407-9-43.

35.

Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation.

Lee YH, Stallcup MR.

Mol Endocrinol. 2009 Apr;23(4):425-33. doi: 10.1210/me.2008-0380. Epub 2009 Jan 22. Review.

36.

Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.

Khalid O, Baniwal SK, Purcell DJ, Leclerc N, Gabet Y, Stallcup MR, Coetzee GA, Frenkel B.

Endocrinology. 2008 Dec;149(12):5984-95. doi: 10.1210/en.2008-0680. Epub 2008 Aug 28.

37.

CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes.

Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR.

Mol Cell. 2008 Aug 22;31(4):510-9. doi: 10.1016/j.molcel.2008.08.001.

38.

The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules.

Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR, Cheng X.

Nat Struct Mol Biol. 2008 Mar;15(3):245-50. doi: 10.1038/nsmb.1384. Epub 2008 Feb 10.

39.

Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation.

Yang CK, Kim JH, Ann DK, Stallcup MR.

BMC Mol Biol. 2008 Jan 25;9:12. doi: 10.1186/1471-2199-9-12.

40.
41.

Role of GAC63 in transcriptional activation mediated by beta-catenin.

Chen YH, Yang CK, Xia M, Ou CY, Stallcup MR.

Nucleic Acids Res. 2007;35(6):2084-92. Epub 2007 Mar 7.

42.

Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

Luo Y, Arita K, Bhatia M, Knuckley B, Lee YH, Stallcup MR, Sato M, Thompson PR.

Biochemistry. 2006 Oct 3;45(39):11727-36.

43.

Interplay of Fli-I and FLAP1 for regulation of beta-catenin dependent transcription.

Lee YH, Stallcup MR.

Nucleic Acids Res. 2006;34(18):5052-9. Epub 2006 Sep 20.

44.
45.

Downstream signaling mechanism of the C-terminal activation domain of transcriptional coactivator CoCoA.

Kim JH, Yang CK, Stallcup MR.

Nucleic Acids Res. 2006 May 22;34(9):2736-50. Print 2006.

46.

Role of GAC63 in transcriptional activation mediated by the aryl hydrocarbon receptor.

Chen YH, Beischlag TV, Kim JH, Perdew GH, Stallcup MR.

J Biol Chem. 2006 May 5;281(18):12242-7. Epub 2006 Mar 2.

47.

Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors.

Lee DY, Northrop JP, Kuo MH, Stallcup MR.

J Biol Chem. 2006 Mar 31;281(13):8476-85. Epub 2006 Feb 4.

48.

A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.

Luo Y, Knuckley B, Lee YH, Stallcup MR, Thompson PR.

J Am Chem Soc. 2006 Feb 1;128(4):1092-3.

49.
50.

Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.

Kim JH, Lee MH, Kim BJ, Kim JH, Han SJ, Kim HY, Stallcup MR.

J Mol Endocrinol. 2005 Dec;35(3):449-64.

PMID:
16326832

Supplemental Content

Loading ...
Support Center